Effect of anti-IL-1β antibody (canakinumab) on insulin secretion rates in impaired glucose tolerance or type 2 diabetes: results of a randomized, placebo-controlled trial

✍ Scribed by A. Rissanen; C. P. Howard; J. Botha; T. Thuren; for the Global Investigators

• Book ID: 115185104
• Publisher: John Wiley and Sons
• Year: 2012
• Tongue: English
• Weight: 547 KB
• Volume: 14
• Category: Article
• ISSN: 1462-8902
• DOI: 10.1111/j.1463-1326.2012.01637.x